FDA Inspection 845938 — Fresenius Kabi Austria GMBH
The FDA completed an inspection of Fresenius Kabi Austria GMBH on July 16, 2013 in Graz. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 16, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Graz (Austria)